- 24973864OWN - NLMSTAT- In-ProcessDA  - 20140924IS  - 1444-2892 (Electronic)IS  - 1443-9506 (Linking)VI  - 23IP  - 10DP  - 2014 OctTI  - Normalisation of haemodynamics in patients with end-stage heart failure with      continuous-flow left ventricular assist device therapy.PG  - 963-9LID - 10.1016/j.hlc.2014.04.259 [doi]LID - S1443-9506(14)00496-X [pii]AB  - BACKGROUND: New generation continuous-flow left ventricular assist devices      (LVADs) utilise centrifugal pumps. Data concerning their effect on patient      haemodynamics, ventricular function and tissue perfusion is limited. We aimed to       document these parameters following HeartWare centrifugal continuous-flow LVAD      (HVAD) implantation and to assess the impact of post-operative right heart      failure (RHF). METHODS: We reviewed 53 consecutive patients (mean age 49.5 +/-      14.1 yrs) with HVAD implanted in the left ventricle, at St. Vincent's Hospital,      Sydney, between January 2007 and August 2012. Available paired right heart      catheterisation (n=35) and echocardiography (n=39) data was reviewed to assess      response of invasive haemodynamics and ventricular function to LVAD support.      RESULTS: A total of 28 patients (53%) were implanted from interim mechanical      circulatory support. Seventeen patients (32%) required short-term post-implant      veno-pulmonary artery extracorporeal membrane oxygenation. At 100 +/- 61 days      post-implant, mean pulmonary artery pressure and mean pulmonary capillary wedge      pressure decreased from 38.8 +/- 7.7 to 22.9 +/- 7.7 mmHg and 28.3 +/- 6.4 to      13.4 +/- 5.4 mmHg respectively (p<0.001). LV end diastolic diameter decreased      from 71.3 +/- 12.7 to 61.1 +/- 13.7 mm and LV end-systolic diameter from 62.7 +/-      12.3 to 53.9 +/- 14.4mm (p<0.001). Aortic regurgitation remained trivial. Serum      sodium increased from 133.3 +/- 5.7 to 139.3 +/- 2.8 mmol/L and creatinine      decreased from 109.1 +/- 42.5 to 74.3 +/- 26.2 mumol/L (p<0.001). Across the      entire cohort, the six-month survival/transplant rate was significantly lower for      RHF patients (72.2%, n=18) compared to those without (96.9%, n=35, p=0.01).      CONCLUSIONS: HVAD support improves haemodynamics, LV dimensions and renal      function. Following implantation with a centrifugal continuous-flow LVAD, RHF      remains a significant risk with a tendency to worse outcomes in the short to      medium term.CI  - Crown Copyright (c) 2014. Published by Elsevier B.V. All rights reserved.FAU - Gupta, SunilAU  - Gupta SAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia.FAU - Woldendorp, KeiAU  - Woldendorp KAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia.FAU - Muthiah, KavithaAU  - Muthiah KAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia;      Faculty of Medicine, Victor Chang Cardiac Research Institute, Sydney, Australia.FAU - Robson, DesireeAU  - Robson DAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia.FAU - Prichard, RoslynAU  - Prichard RAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia.FAU - Macdonald, Peter SAU  - Macdonald PSAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia;      Faculty of Medicine, Victor Chang Cardiac Research Institute, Sydney, Australia.FAU - Keogh, Anne MAU  - Keogh AMAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia;      Faculty of Medicine, Victor Chang Cardiac Research Institute, Sydney, Australia.FAU - Kotlyar, EugeneAU  - Kotlyar EAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia.FAU - Jabbour, AndrewAU  - Jabbour AAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, Victor Chang Cardiac Research Institute, Sydney, Australia.FAU - Dhital, KumudAU  - Dhital KAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia.FAU - Granger, EmilyAU  - Granger EAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia.FAU - Spratt, PhillipAU  - Spratt PAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia.FAU - Jansz, PaulAU  - Jansz PAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia.FAU - Hayward, Christopher SAU  - Hayward CSAD  - Heart Failure and Transplant Unit, St. Vincent's Hospital, Sydney, Australia;      Faculty of Medicine, The University of New South Wales, Sydney, Australia;      Faculty of Medicine, Victor Chang Cardiac Research Institute, Sydney, Australia.       Electronic address: cshayward@stvincents.com.au.LA  - engPT  - Journal ArticleDEP - 20140603PL  - AustraliaTA  - Heart Lung CircJT  - Heart, lung & circulationJID - 100963739SB  - IMOTO - NOTNLMOT  - Clinical outcomesOT  - HaemodynamicsOT  - Heart failureOT  - Heart-assist devicesOT  - Left ventricular functionOT  - Pulmonary hypertensionEDAT- 2014/06/30 06:00MHDA- 2014/06/30 06:00CRDT- 2014/06/30 06:00PHST- 2013/10/13 [received]PHST- 2014/01/09 [revised]PHST- 2014/04/13 [accepted]PHST- 2014/06/03 [aheadofprint]AID - S1443-9506(14)00496-X [pii]AID - 10.1016/j.hlc.2014.04.259 [doi]PST - ppublishSO  - Heart Lung Circ. 2014 Oct;23(10):963-9. doi: 10.1016/j.hlc.2014.04.259. Epub 2014      Jun 3.